{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T11:02:07Z","timestamp":1793703727661,"version":"4.5.1"},"reference-count":85,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100024662","name":"Salix Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100024662","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","amjmed.com","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.amjmed.2024.05.015","type":"journal-article","created":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T16:07:55Z","timestamp":1716394075000},"page":"929-938","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Key Insights and Clinical Pearls in the Identification and Management of Cirrhosis and Its Complications"],"prefix":"10.1016","volume":"137","author":[{"given":"Steven L.","family":"Flamm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"41","key":"10.1016\/j.amjmed.2024.05.015_bib0001","doi-asserted-by":"crossref","first-page":"5910","DOI":"10.3748\/wjg.v28.i41.5910","article-title":"Epidemiology of liver cirrhosis and associated complications: current knowledge and future directions","volume":"28","author":"Liu","year":"2022","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.amjmed.2024.05.015_bib0002","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies","volume":"44","author":"D'Amico","year":"2006","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.amjmed.2024.05.015_bib0003","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2021.06.018","article-title":"Towards a new definition of decompensated cirrhosis","volume":"76","author":"D'Amico","year":"2022","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.amjmed.2024.05.015_bib0004","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.1997","article-title":"Trends in the burden of chronic liver disease among hospitalized US adults","volume":"3","author":"Hirode","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"10","key":"10.1016\/j.amjmed.2024.05.015_bib0005","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.14309\/ajg.0000000000001292","article-title":"Trends in the economic burden of chronic liver diseases and cirrhosis in the United States: 1996-2016","volume":"116","author":"Ma","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"18","key":"10.1016\/j.amjmed.2024.05.015_bib0006","doi-asserted-by":"crossref","first-page":"488","DOI":"10.15585\/mmwr.mm7218a3","article-title":"Provisional mortality data \u2013 United States, 2022","volume":"72","author":"Ahmad","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.amjmed.2024.05.015_bib0007","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/801983","article-title":"A primer on detecting cirrhosis and caring for these patients without causing harm","volume":"2011","author":"Runyon","year":"2011","journal-title":"Int J Hepatol"},{"issue":"5","key":"10.1016\/j.amjmed.2024.05.015_bib0008","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jceh.2023.01.016","article-title":"Comparison of guidelines for the screening, diagnosis, and noninvasive assessment of nonalcoholic fatty liver disease","volume":"13","author":"Chow","year":"2023","journal-title":"J Clin Exp Hepatol"},{"issue":"4","key":"10.1016\/j.amjmed.2024.05.015_bib0009","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1053\/j.gastro.2023.06.013","article-title":"AGA clinical practice update on the role of noninvasive biomarkers in the evaluation and management of nonalcoholic fatty liver disease: expert review","volume":"165","author":"Wattacheril","year":"2023","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.amjmed.2024.05.015_bib0010","doi-asserted-by":"crossref","first-page":"e13508","DOI":"10.1111\/eci.13508","article-title":"Procedure-related bleeding risk in patients with cirrhosis and severe thrombocytopenia","volume":"51","author":"Alvaro","year":"2021","journal-title":"Eur J Clin Invest"},{"issue":"5","key":"10.1016\/j.amjmed.2024.05.015_bib0011","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"issue":"30","key":"10.1016\/j.amjmed.2024.05.015_bib0012","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.3748\/wjg.v28.i30.4061","article-title":"Thrombocytopenia in chronic liver disease: physiopathology and new therapeutic strategies before invasive procedures","volume":"28","author":"Gallo","year":"2022","journal-title":"World J Gastroenterol"},{"issue":"38","key":"10.1016\/j.amjmed.2024.05.015_bib0013","doi-asserted-by":"crossref","first-page":"5849","DOI":"10.3748\/wjg.v26.i38.5849","article-title":"Longitudinal decrease in platelet counts as a surrogate marker of liver fibrosis","volume":"26","author":"Gotlieb","year":"2020","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.amjmed.2024.05.015_bib0014","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.amjmed.2024.05.015_bib0015","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep4.1018","article-title":"Nonalcoholic fatty liver disease\u2013related cirrhosis is commonly unrecognized and associated with hepatocellular carcinoma","volume":"1","author":"Bertot","year":"2017","journal-title":"Hepatol Commun"},{"issue":"6","key":"10.1016\/j.amjmed.2024.05.015_bib0016","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.cgh.2009.02.021","article-title":"Incidence, prevalence, and clinical significance of abnormal hematologic indices in compensated cirrhosis","volume":"7","author":"Qamar","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.amjmed.2024.05.015_bib0017","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5305691","article-title":"Autoimmune hepatitis with concomitant idiopathic thrombocytopenic purpura diagnosed by transjugular liver biopsy","volume":"2018","author":"Fukuda","year":"2018","journal-title":"Case Reports Hepatol"},{"issue":"2","key":"10.1016\/j.amjmed.2024.05.015_bib0018","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/BF02389532","article-title":"Primary biliary cirrhosis associated with idiopathic thrombocytopenic purpura","volume":"31","author":"Mizukami","year":"1996","journal-title":"J Gastroenterol"},{"issue":"2","key":"10.1016\/j.amjmed.2024.05.015_bib0019","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/j.clinre.2012.11.001","article-title":"Autoimmune hepatitis-primary biliary cirrhosis overlap syndrome concomitant with immune hemolytic anemia and immune thrombocytopenic purpura (Evans syndrome)","volume":"37","author":"Korkmaz","year":"2013","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"8","key":"10.1016\/j.amjmed.2024.05.015_bib0020","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1111\/j.1572-0241.2002.05845.x","article-title":"Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection","volume":"97","author":"Pockros","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"suppl 1","key":"10.1016\/j.amjmed.2024.05.015_bib0021","first-page":"S1","article-title":"Missed diagnosis of cirrhosis in the inpatient setting","volume":"17","author":"Amin","year":"2022","journal-title":"J Hosp Med"},{"issue":"12","key":"10.1016\/j.amjmed.2024.05.015_bib0022","first-page":"1353","article-title":"Cirrhosis: diagnosis, management, and prevention","volume":"84","author":"Starr","year":"2011","journal-title":"Am Fam Physician"},{"issue":"3","key":"10.1016\/j.amjmed.2024.05.015_bib0023","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.amjms.2018.06.008","article-title":"Complications of cirrhosis in primary care: recognition and management of hepatic encephalopathy","volume":"356","author":"Flamm","year":"2018","journal-title":"Am J Med Sci"},{"issue":"11","key":"10.1016\/j.amjmed.2024.05.015_bib0024","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1007\/s11606-023-08093-8","article-title":"Real-world primary care data comparing ALT and FIB-4 in predicting future severe liver disease outcomes","volume":"38","author":"Schreiner","year":"2023","journal-title":"J Gen Intern Med"},{"issue":"11","key":"10.1016\/j.amjmed.2024.05.015_bib0025","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.4254\/wjh.v13.i11.1688","article-title":"Abnormal liver enzymes: a review for clinicians","volume":"13","author":"Kalas","year":"2021","journal-title":"World J Hepatol"},{"issue":"7","key":"10.1016\/j.amjmed.2024.05.015_bib0026","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1007\/s10620-012-2098-3","article-title":"The spontaneous course of liver enzymes and its correlation in nonalcoholic fatty liver disease","volume":"57","author":"Charatcharoenwitthaya","year":"2012","journal-title":"Dig Dis Sci"},{"issue":"4","key":"10.1016\/j.amjmed.2024.05.015_bib0027","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2036.2008.03896.x","article-title":"Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels","volume":"29","author":"Wong","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.amjmed.2024.05.015_bib0028","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.amjms.2021.09.012","article-title":"Normal or near normal aminotransferase levels in patients with alcoholic cirrhosis","volume":"363","author":"Sullivan","year":"2022","journal-title":"Am J Med Sci"},{"issue":"11","key":"10.1016\/j.amjmed.2024.05.015_bib0029","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1001\/jama.2009.351","article-title":"Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications","volume":"301","author":"Volkow","year":"2009","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.amjmed.2024.05.015_bib0030","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5009\/gnl230072","article-title":"Recent advances in the pathogenesis and clinical evaluation of portal hypertension in chronic liver disease","volume":"18","author":"Kotani","year":"2024","journal-title":"Gut Liver"},{"issue":"4","key":"10.1016\/j.amjmed.2024.05.015_bib0031","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII \u2013 renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.amjmed.2024.05.015_bib0032","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/hep.1840070124","article-title":"Compensated cirrhosis: natural history and prognostic factors","volume":"7","author":"Gin\u00e9s","year":"1987","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.amjmed.2024.05.015_bib0033","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/MCG.0000000000001652","article-title":"Improved mortality but increased economic burden of disease in compensated and decompensated cirrhosis: a US national perspective","volume":"57","author":"Radadiya","year":"2023","journal-title":"J Clin Gastroenterol"},{"issue":"6","key":"10.1016\/j.amjmed.2024.05.015_bib0034","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/s41575-023-00759-2","article-title":"Global epidemiology of cirrhosis \u2013 aetiology, trends and predictions","volume":"20","author":"Huang","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.amjmed.2024.05.015_bib0035","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/apt.15679","article-title":"Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare data","volume":"51","author":"Loomba","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.amjmed.2024.05.015_bib0036","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/hep.26972","article-title":"Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation","volume":"59","author":"Martin","year":"2014","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.amjmed.2024.05.015_bib0037","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jceh.2022.12.015","article-title":"Spleen stiffness measurement across the spectrum of liver disease patients in real-world practice","volume":"13","author":"Lantinga","year":"2023","journal-title":"J Clin Exp Hepatol"},{"issue":"9","key":"10.1016\/j.amjmed.2024.05.015_bib0038","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S2468-1253(23)00150-4","article-title":"Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis","volume":"8","author":"Dajti","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.amjmed.2024.05.015_bib0039","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.cld.2021.01.005","article-title":"Noninvasive detection of clinically significant portal hypertension in compensated advanced chronic liver disease","volume":"25","author":"Vuille-Lessard","year":"2021","journal-title":"Clin Liver Dis"},{"issue":"11","key":"10.1016\/j.amjmed.2024.05.015_bib0040","doi-asserted-by":"crossref","first-page":"5280","DOI":"10.1007\/s10620-021-07334-2","article-title":"Clinical outcomes in patients with advanced chronic liver disease and hepatic venous pressure gradient \u226410 mm Hg","volume":"67","author":"Jindal","year":"2022","journal-title":"Dig Dis Sci"},{"issue":"4","key":"10.1016\/j.amjmed.2024.05.015_bib0041","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jhep.2022.05.021","article-title":"Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis","volume":"77","author":"Villanueva","year":"2022","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.amjmed.2024.05.015_bib0042","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/hep.32737","article-title":"Nonselective beta blockers, hepatic decompensation, and mortality in cirrhosis: a national cohort study","volume":"77","author":"Serper","year":"2023","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.amjmed.2024.05.015_bib0043","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12876-023-02656-z","article-title":"Alcohol treatment discussions and clinical outcomes among patients with alcohol-related cirrhosis","volume":"23","author":"Alexandre","year":"2023","journal-title":"BMC Gastroenterol"},{"issue":"5","key":"10.1016\/j.amjmed.2024.05.015_bib0044","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/alcalc\/agac015","article-title":"Identifying alcohol use disorder in patients with cirrhosis reduces 30-days readmission rate","volume":"57","author":"Singal","year":"2022","journal-title":"Alcohol Alcohol"},{"issue":"4","key":"10.1016\/j.amjmed.2024.05.015_bib0045","doi-asserted-by":"crossref","first-page":"e0093","DOI":"10.1097\/HC9.0000000000000093","article-title":"Medications for alcohol use disorder improve survival in patients with hazardous drinking and alcohol-associated cirrhosis","volume":"7","author":"Rabiee","year":"2023","journal-title":"Hepatol Commun"},{"issue":"1","key":"10.1016\/j.amjmed.2024.05.015_bib0046","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.30866","article-title":"Diagnosis and treatment of alcohol-associated liver diseases: 2019 Practice Guidance from the American Association for the Study of Liver Diseases","volume":"71","author":"Crabb","year":"2020","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.amjmed.2024.05.015_bib0047","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41575-021-00527-0","article-title":"Management of alcohol use disorder in patients with cirrhosis in the setting of liver transplantation","volume":"19","author":"Arab","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.amjmed.2024.05.015_bib0048","doi-asserted-by":"crossref","first-page":"30","DOI":"10.14309\/ajg.0000000000002572","article-title":"ACG clinical guideline: alcohol-associated liver disease","volume":"119","author":"Jophlin","year":"2024","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.amjmed.2024.05.015_bib0049","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jceh.2021.12.003","article-title":"Vaccination in chronic liver disease: an update","volume":"12","author":"Alukal","year":"2022","journal-title":"J Clin Exp Hepatol"},{"issue":"3","key":"10.1016\/j.amjmed.2024.05.015_bib0050","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/hep.32049","article-title":"Malnutrition, frailty, and sarcopenia in patients with cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases","volume":"74","author":"Lai","year":"2021","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.amjmed.2024.05.015_bib0051","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/hepr.13192","article-title":"Association between sarcopenia and osteoporosis in chronic liver disease","volume":"48","author":"Hayashi","year":"2018","journal-title":"Hepatol Res"},{"issue":"2","key":"10.1016\/j.amjmed.2024.05.015_bib0052","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/cld.951","article-title":"PRO: esophagogastroduodenoscopy is the preferred modality to screen for the diagnosis of esophageal and gastric varices when the diagnosis of cirrhosis is made","volume":"16","author":"Richardson","year":"2020","journal-title":"Clin Liver Dis (Hoboken)"},{"issue":"4","key":"10.1016\/j.amjmed.2024.05.015_bib0053","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.cgh.2020.06.022","article-title":"Including ratio of platelets to liver stiffness improves accuracy of screening for esophageal varices that require treatment","volume":"19","author":"Berger","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.amjmed.2024.05.015_bib0054","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1097\/HEP.0000000000000647","article-title":"AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis","volume":"79","author":"Kaplan","year":"2024","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.amjmed.2024.05.015_bib0055","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1002\/hep.30779","article-title":"Quality measures, all-cause mortality, and health care use in a national cohort of veterans with cirrhosis","volume":"70","author":"Serper","year":"2019","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.amjmed.2024.05.015_bib0056","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/hep.31884","article-title":"Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the American Association for the Study of Liver Diseases","volume":"74","author":"Biggins","year":"2021","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.amjmed.2024.05.015_bib0057","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.amjmed.2024.05.015_bib0058","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1053\/j.gastro.2019.12.053","article-title":"AGA Clinical Practice Update on screening and surveillance for hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: expert review","volume":"158","author":"Loomba","year":"2020","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.amjmed.2024.05.015_bib0059","doi-asserted-by":"crossref","first-page":"411","DOI":"10.14309\/ajg.0000000000001000","article-title":"Rates and predictors of undergoing different hepatocellular carcinoma screening tests in patients with cirrhosis","volume":"116","author":"Kim","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.amjmed.2024.05.015_bib0060","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.23504","article-title":"Barriers to surveillance for hepatocellular carcinoma in a multicenter cohort","volume":"5","author":"Parikh","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.amjmed.2024.05.015_bib0061","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","article-title":"AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma","volume":"78","author":"Singal","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2024.05.015_bib0062","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8542179","article-title":"Prevalence of hepatic encephalopathy from a commercial medical claims database in the United States","volume":"2021","author":"Potnis","year":"2021","journal-title":"Int J Hepatol"},{"issue":"8","key":"10.1016\/j.amjmed.2024.05.015_bib0063","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1080\/00365521.2023.2175619","article-title":"Decompensation as initial presentation in patients with liver cirrhosis is associated with an increased risk of future decompensation and mortality","volume":"58","author":"de Wit","year":"2023","journal-title":"Scand J Gastroenterol"},{"issue":"17","key":"10.1016\/j.amjmed.2024.05.015_bib0064","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","article-title":"Prospective study of outcomes in adults with nonalcoholic fatty liver disease","volume":"385","author":"Sanyal","year":"2021","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.amjmed.2024.05.015_bib0065","doi-asserted-by":"crossref","first-page":"833","DOI":"10.14309\/ajg.0000000000002018","article-title":"Assessing the risk of further decompensation and survival in patients with cirrhosis with variceal bleeding as their first decompensation event","volume":"118","author":"Gupta","year":"2022","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.amjmed.2024.05.015_bib0066","doi-asserted-by":"crossref","first-page":"475","DOI":"10.14309\/ajg.0000000000002189","article-title":"Dementia frequently coexists with hepatic encephalopathy but not other cirrhosis complications in US veterans","volume":"118","author":"Adejumo","year":"2023","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.amjmed.2024.05.015_bib0067","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jhep.2022.06.001","article-title":"EASL Clinical Practice Guidelines on the management of hepatic encephalopathy","volume":"77","year":"2022","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.amjmed.2024.05.015_bib0068","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0276914","article-title":"Liver diseases as a novel risk factor for delirium in the ICU\u2014delirium and hepatic encephalopathy are two distinct entities","volume":"17","author":"Denk","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.amjmed.2024.05.015_bib0069","article-title":"Predisposing and precipitating risk factors for delirium in gastroenterology and hepatology: subgroup analysis of 718 patients from a hospital-wide prospective cohort study","volume":"9","author":"Hildenbrand","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"10.1016\/j.amjmed.2024.05.015_bib0070","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/hep.27210","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver","volume":"60","author":"Vilstrup","year":"2014","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.amjmed.2024.05.015_bib0071","doi-asserted-by":"crossref","first-page":"659","DOI":"10.12788\/jhm.2794","article-title":"Ammonia levels and hepatic encephalopathy in patients with known chronic liver disease","volume":"12","author":"Ninan","year":"2017","journal-title":"J Hosp Med"},{"issue":"11","key":"10.1016\/j.amjmed.2024.05.015_bib0072","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1111\/imj.16053","article-title":"Serum ammonia does not guide management and is overutilised in patients with cirrhosis in hospital settings","volume":"53","author":"Hannah","year":"2023","journal-title":"Intern Med J"},{"issue":"5","key":"10.1016\/j.amjmed.2024.05.015_bib0073","doi-asserted-by":"crossref","first-page":"723","DOI":"10.14309\/ajg.0000000000000343","article-title":"Ammonia levels do not guide clinical management of patients with hepatic encephalopathy caused by cirrhosis","volume":"115","author":"Haj","year":"2020","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.amjmed.2024.05.015_bib0074","doi-asserted-by":"crossref","first-page":"e895","DOI":"10.1016\/j.cgh.2021.01.016","article-title":"A prospective, blinded assessment of ammonia testing demonstrates low utility among front-line clinicians","volume":"20","author":"Gonzalez","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"18","key":"10.1016\/j.amjmed.2024.05.015_bib0075","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.3748\/wjg.v26.i18.2221","article-title":"Prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with current standards of care","volume":"26","author":"Bohra","year":"2020","journal-title":"World J Gastroenterol"},{"issue":"7","key":"10.1016\/j.amjmed.2024.05.015_bib0076","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/ajg.2012.113","article-title":"Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy","volume":"107","author":"Agrawal","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"10.1016\/j.amjmed.2024.05.015_bib0077","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/ajg.2013.219","article-title":"A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy","volume":"108","author":"Sharma","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.amjmed.2024.05.015_bib0078","series-title":"Xifaxan\u00ae (Rifaximin) Tablets, for Oral Use","year":"2022"},{"issue":"12","key":"10.1016\/j.amjmed.2024.05.015_bib0079","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","article-title":"Rifaximin treatment in hepatic encephalopathy","volume":"362","author":"Bass","year":"2010","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.amjmed.2024.05.015_bib0080","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1016\/j.cgh.2019.12.035","article-title":"Coordination of care is associated with survival and health care utilization in a population-based study of patients with cirrhosis","volume":"18","author":"Cohen-Mekelburg","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.amjmed.2024.05.015_bib0081","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/apt.15749","article-title":"Outcomes after hepatic encephalopathy in population-based cohorts of patients with cirrhosis","volume":"51","author":"Tapper","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.amjmed.2024.05.015_bib0082","doi-asserted-by":"crossref","first-page":"491","DOI":"10.14309\/ajg.0000000000001608","article-title":"An electronic decision support intervention reduces readmissions for patients with cirrhosis","volume":"117","author":"Louissaint","year":"2022","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.amjmed.2024.05.015_bib0083","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/10600280221100537","article-title":"Lack of access to rifaximin upon hospital discharge is frequent and results in increased hospitalizations for hepatic encephalopathy","volume":"57","author":"Stoll","year":"2023","journal-title":"Ann Pharmacother"},{"issue":"17-18","key":"10.1016\/j.amjmed.2024.05.015_bib0084","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1111\/jocn.13298","article-title":"Being an informal caregiver for a relative with liver cirrhosis and overt hepatic encephalopathy: a phenomenological study","volume":"25","author":"K\u00fcnzler-Heule","year":"2016","journal-title":"J Clin Nurs"},{"issue":"3","key":"10.1016\/j.amjmed.2024.05.015_bib0085","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.dld.2019.12.002","article-title":"Hospital readmission of patients with hepatic encephalopathy: is the introduction of the formal caregiver useful in care management?","volume":"52","author":"Balbinot","year":"2020","journal-title":"Dig Liver Dis"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934324003267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934324003267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T18:41:05Z","timestamp":1732041665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934324003267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":85,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0002934324003267"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2024.05.015","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Key Insights and Clinical Pearls in the Identification and Management of Cirrhosis and Its Complications","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2024.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}